Approved Hospital Formulary
Add Formweb to your mobile device
HIGH ALERT: Please review policy carefully.
Search results for:
teclistamab
teclistamab
Brand names: Tecvayli
| Form | Strength |
|---|---|
| SOLUTION, SUBCUTANEOUS | cqyv 10 mg/mL; cqyv 90 mg/mL |
Last updated: Sep. 1, 2023
HIGH ALERT: Please review policy carefully.
teclistamab
| Form | Strength |
|---|---|
| SOLUTION, SUBCUTANEOUS | cqyv 10 mg/mL; cqyv 90 mg/mL |
Formulary restriction:
Inpatient: Patients with relapsed/refractory multiple myeloma for the initial step-up dosing cycle only; restricted to hematology service. Consider subsequent repeat step-up doses as non-formulary with case-by-case evaluation. Secure payor authorization for the medication and the admission, prior to drug procurement and patient admission.
Outpatient: Defer to payor clinical criteria.